Platelet rich plasma in Xeno-Free stem cell culture: The impact of platelet count and processing method

Current Stem Cell Research and Therapy

Volumn 7, Issue 5, 2012, Pages 329-335

  Pawitan, Jeanne Adiwinata ^a  

^a UNIVERSITY OF INDONESIA   (Indonesia)

Author keywords

FBS substitute; Platelet derived growth factor; Platelet lysate; Platelet rich plasma; Stem cell; Xeno free

Indexed keywords

ADENOSINE DIPHOSPHATE; CALCIUM CHLORIDE; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR AB; SOMATOMEDIN C; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; TRANSFORMING GROWTH FACTOR BETA1;

ADIPOSE DERIVED STEM CELL; ARTICLE; BONE REMODELING; CANCER CELL CULTURE; CELL ASSAY; CELL CULTURE; CELL GROWTH; CELL LYSATE; CELL PROLIFERATION; FETAL CALF SERUM; FREEZING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; LEUKEMIA CELL LINE; LIQUID CULTURE; MESENCHYMAL STEM CELL; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SOFT TISSUE; SPINAL CORD REGENERATION; STEM CELL; STEM CELL CULTURE; THAWING; THROMBOCYTE COUNT; THROMBOCYTE POOR PLASMA; THROMBOCYTE RICH PLASMA; TISSUE ENGINEERING;

ADIPOSE TISSUE; ANIMALS; ANTIGENS, HETEROPHILE; BONE MARROW CELLS; CATTLE; CELL CULTURE TECHNIQUES; CELL GROWTH PROCESSES; CELLS, CULTURED; HUMANS; MESENCHYMAL STROMAL CELLS; PLATELET COUNT; PLATELET-RICH PLASMA; REGENERATIVE MEDICINE; SERUM; SPECIMEN HANDLING;

EID: 84867030578     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488812802481508     Document Type: Article

References (15)

1. Bieback K, Schallmoser K, Klüter H, Strunk D. Clinical protocols for the isolation and expansion of mesenchymal stromal cells. Transfus Med Hemother 2008; 35(4): 286-94.
2. Spees JL, Gregory CA, Singh H, et al. Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther 2004; 9(5): 747-56.
3. Sankaranarayanan K, Chandana T, Gency Ponrose G, et al. Humanized substitutes for animal sera in human mesenchymal stem cell culture and differentiation. Cell Biol Int 2011; Apr 15. [Epub ahead of print] doi:10.1042/CBI20100649 (CBI20100649).
4. Rauch C, Feifel E, Amann EM, et al. Alternatives to the Use of Fetal Bovine Serum: Human Platelet Lysates as a Serum Substitute in Cell Culture Media. ALTEX 2011; 28(4): 305-16.
5. Kocaoemer A, Kern S, Klüter H, Bieback K. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 2007; 25(5): 1270-8.
6. Bieback K, Hecker A, Kocaömer A, et al. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 2009; 27(9): 2331-41.
7. Cho HS, Song IH, Park SY, Sung MC, Ahn MW, Song KE. Individual variation in growth factor concentrations in platelet-rich plasma and its influence on human mesenchymal stem cells. Korean J Lab Med 2011; 31(3): 212-8.
8. Goedecke A, Wobus M, Krech M, et al. Differential effect of platelet- rich plasma and fetal calf serum on bone marrow-derived human mesenchymal stromal cells expanded in vitro. J Tissue Eng Regen Med 2011; 5(8): 648-54.
9. Huang Q, Wang YD, Wu T, Jiang S, Hu YL, Pei GX. Preliminary separation of the growth factors in platelet-rich plasma: effects on the proliferation of human marrow-derived mesenchymal stem cells. Chin Med J (Engl) 2009; 122(1): 83-87.
10. Kurita M, Aiba-Kojima E, Shigeura T, et al. Differential effects of three preparations of human serum on expansion of various types of human cells. Plast Reconstr Surg 2008; 122(2): 438-48.
11. Centeno CJ, Schultz JR, Cheever M, Robinson B, Freeman M, Marasco W. Safety and complications reporting on the reimplantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Curr Stem Cell Res Ther 2010; 5 (1): 81-93.
12. Kakudo N, Minakata T, Mitsui T, Kushida S, Notodihardjo FZ, Kusumoto K. Proliferation-promoting effect of platelet-rich plasma on human adipose-derived stem cells and human dermal fibroblasts. Plast Reconstr Surg 2008; 122(5): 1352-60.
13. Spees JL, Gregory CA, Singh H, et al. Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther 2004; 9: 747-56.
14. Lawson JH. The clinical use and immunologic impact of thrombin in surgery. Semin Thromb Hemost 2006; 32 (Suppl 1): 98-110.
15. Kilian O, Flesch I, Wenisch S, et al. Effects of platelet growth factors on human mesenchymal stem cells and human endothelial cells in vitro. Eur J Med Res 2004; 9(7): 337-44.